Others

Breast cancer (BC) constitutes the most common female malignancy and nowadays molecular classification of subtypes is crucial to estimate a patient’s prognosis and administer appropriate treatment. It allows tailoring therapeutic...

In our recent paper, we introduce Random Similarity Forest, a machine learning algorithm capable of handling datasets with features of arbitrary data types while retaining each feature’s characteristic. As evidenced...

MNM Bioscience began as a bioinformatics company that curates data and then builds artificial intelligence-based algorithms, but it is now looking to branch out into oncology drug target discovery. About...

MNM Bioscience Inc. announced that it had filed a provisional patent application, entitled “METHODS AND SYSTEMS FOR PREDICTING THERAPEUTIC RESPONSIVENESS” for Random Similarity Forest (RSF), a classifier that performs a...

MNM Biosciences, in co-operation with leading Polish cancer centers, has recently published a breakthrough publication concerning breast cancer diagnostics.  The article in Molecular Diagnosis & Therapy presents an innovative method...

Our understanding of life is based upon the interpretation of macromolecular structures and their dynamics. Almost 90% of currently known macromolecular models originated from electron density maps constructed using X-ray...

Patients referred for HNF1B testing present very heterogeneous phenotypes. Despite suggestive characteristics, many do not harbor mutations in HNF1B. The authors’ objective was to evaluate the clinical characteristics of probands...

Neurofibromatosis type 1 is an autosomal dominantly inherited tumour predisposition syndrome, in which inactivating mutations in the neurofibromatosis type 1 gene (NF1) lead to prolonged activation of the signalling via...

Molecular monitoring of treatment response in patients with chronic myelogenous leukemia is performed using the Europe Against Cancer (EAC) qPCR assay using the International Scale (IS). The assay amplifies both...

Mutation analysis and cytogenetic testing in clear cell renal cell carcinoma (ccRCC) is not yet implemented in a routine diagnostics of ccRCC. The authors characterized the chromosomal alterations in 83...

The early diagnosis and monitoring of clear-cell Renal Cell Carcinoma (ccRCC), which is the most common renal malignancy, remains challenging. The late diagnosis and lack of tools that can be...

Primary ciliary dyskinesia (PCD) is a rare disease with autosomal recessive inheritance, caused mostly by bi-allelic gene mutations that impair motile cilia structure and function. Currently, there are no causal...

Somatic rearrangements contribute to the mutagenized landscape of cancer genomes. Here, the authors systematically interrogated rearrangements in 560 breast cancers by using a piecewise constant fitting approach. They identified 33...

Mutational signatures are patterns of mutations that arise during tumorigenesis. The authors present an enhanced, practical framework for mutational signature analyses. Applying these methods on 3,107 whole genome sequenced (WGS) primary...

In multiple myeloma, next-generation sequencing (NGS) has expanded our knowledge of genomic lesions, and highlighted a dynamic and heterogeneous composition of the tumor. Here the authors used NGS to characterize...

Sex differences have been observed in multiple facets of cancer epidemiology, treatment and biology, and in most cancers outside the sex organs. Efforts to link these clinical differences to specific...

Solid tumor patients are at a heightened risk for developing therapy-related myeloid neoplasms (tMN). Recent studies show evidence of somatic mutations in leukemia-associated genes in normal healthy individuals, referred to...

Homologous recombination deficiency (HRD) is a defining characteristic in BRCA-deficient breast tumors caused by genetic or epigenetic alterations in key pathway genes. The authors investigated the frequency of BRCA1 promoter...

Whole genome sequencing of human tumours has revealed distinct patterns of mutation that hint at the causative origins of cancer. Experimental investigations of the mutations and mutation spectra induced by...

Global loss of DNA methylation and CpG island (CGI) hypermethylation are key epigenomic aberrations in cancer. Global loss manifests itself in partially methylated domains (PMDs) which extend up to megabases....

Complex clusters of rearrangements are a challenge in interpretation of cancer genomes. Some clusters of rearrangements demarcate clear amplifications of driver oncogenes but others are less well understood. The authors...

Mutational signatures are patterns of mutations that arise during tumorigenesis. The authors present an enhanced, practical framework for mutational signature analyses. Applying these methods on 3,107 whole genome sequenced (WGS) primary...

Somatic rearrangements contribute to the mutagenized landscape of cancer genomes. The authors systematically interrogated rearrangements in 560 breast cancers by using a piecewise constant fitting approach. Identified 33 hotspots of...

The multiple myeloma (MM) genome is heterogeneous and evolves through preclinical and post-diagnosis phases. The authors report a catalog and hierarchy of driver lesions using sequences from 67 multiple myeloma...

Immunotherapy with checkpoint inhibitors revolutionized melanoma treatment in both the adjuvant and metastatic setting, yet not all metastatic patients respond, and metastatic disease still often recurs among immunotherapy-treated patients with...

Immunotherapy is often perceived as a relatively recent advance. In reality, however, one should be looking for the beginnings of cancer immunotherapy under different names as far as in the...

In the Perspective work-issued today, we highlight the possible genetic background of COVID-19 interindividual variability, ranging from asymptomatic infection to life-threatening disease. Despite many international efforts, the genetic and immunological...

Primary ciliary dyskinesia (PCD) is a motile ciliopathy, whose symptoms include airway infections, male infertility and situs inversus. Apart from the typical forms of PCD, rare syndromic PCD forms exist....

Translational readthrough of premature termination codons (PTCs) induced by pharmacological compounds has proven to be an effective way of restoring functional protein expression and reducing symptoms in several genetic disorders....